Patient Protection and Affordable Care Act (PPACA); Emerging Infections Program (EIP); Enhancing Epidemiology and Laboratory Capacity (U01)

The summary for the Patient Protection and Affordable Care Act (PPACA); Emerging Infections Program (EIP); Enhancing Epidemiology and Laboratory Capacity (U01) Federal Grant is detailed below. It contains information such as the Catalog of Federal Domestic Assistance (CFDA) number, who is eligible for the grant, how much grant money will be awarded, important deadlines, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed in the Grant Announcement Contact section. If these sections are incomplete, please visit the website of the government agency that is offering this grant.


	Federal Grant Title:	Patient Protection and Affordable Care Act (PPACA); Emerging Infections Program (EIP); Enhancing Epidemiology and Laboratory Capacity (U01)
	CFDA Number:	93.521
	CFDA Description:	The Affordable Care Act: Building Epidemiology, Laboratory, and Health Information Systems Capacity in the Epidemiology
	Federal Agency Name:	Centers for Disease Control and Prevention
	Category of Funding Activity:	Health
	Category Explanation:	Information not provided
	Opportunity Category:	Discretionary
	Funding Opportunity Number:	RFA-CI-10-003
	Document Type:	Modification to Previous Grants Notice
	Funding Instrument Type:	Cooperative Agreement
	Posted Date:	Aug 17, 2010
	Creation Date:	Aug 17, 2010
	Original Closing Date for Applications:	Aug 27, 2010
	Current Closing Date for Applications:	Aug 27, 2010
	Archive Date:	Sep 26, 2010
	Expected Number of Awards:	10
	Estimated Total Program Funding:	$4,500,000
	Federal Grant Award Ceiling:	$650,000
	Federal Grant Award Floor:	$0
	Cost Sharing or Matching Requirement:	No

Applicants Eligible for this Grant: Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility: Eligible Institutions You may submit an application(s) if your organization has any of the following characteristics: Eligibility for these awards is limited to current grantees under the EIP cooperative agreement program which are the health departments of California, Colorado, Connecticut, Georgia, Maryland, Minnesota, New Mexico, New York, Tennessee, and Oregon or their Bona Fide Agents. These 10 grantees are currently funded under EIP Funding Opportunity Announcement numbers CI02-174 (NM) and CI05-026 (CA, CO, CT, GA, MD, MN, NM, NY, TN, OR). Eligibility is limited to current EIP grantees because this ACA activity builds upon existing EIP infrastructure, capacities, and activities. Along with assuring adequate scientific and technical resources, using the existing EIP network will also allow these resources to be implemented efficiently and effectively to support epidemiology and laboratory capacity in the nation's public health system and inform prevention efforts to improve the quality and reduce the cost of healthcare, consistent with the intention of ACA.
Grant Description: The purpose of this EIP-ACA FOA is to support state and local health departments' surveillance infrastructure through enhancement of the epidemiology and laboratory capacity of the existing EIP network. Over the past 15 years, the EIP network has proved to be a national resource for conducting active, population-based surveillance and special studies for invasive bacterial diseases, foodborne pathogens, healthcare associated infections (HAIs), influenza, and many other infectious diseases. The network has been instrumental in measuring the impact of the 7-valent pneumococcal conjugate vaccine, informing and evaluating treatment guidelines for Group B Streptococcus, estimating the burden of foodborne illness, documenting the emergence of community-associated methicillin-resistant Staphylococcus aureus, and monitoring the safety of the 2009 H1N1 vaccine as part of the influenza vaccine safety network (http://www.cdc.gov/ncpdcid/deiss/eip/publications.html). EIP activities and special studies frequently shift according to priorities for infectious disease emergency response and program areas. The flexibility of the network is ideal for implementing activities in response to rapidly changing scientific priorities. These investments in the basic infrastructure support multiple activities at each site and are critical for a comprehensive, efficient, and coordinated approach to general program management from which all activities benefit. EIP sites may conduct up to 65 different surveillance and research activities related to infectious diseases during the course of a year. These activities require investments in personnel time to implement or modify, including building collaborative relationships with local hospitals, laboratories, and healthcare providers; submitting applications to multiple institutional review boards for dozens of studies; hiring, supervising and training staff; facilitating information exchange between CDC, local epidemiologists and laboratories; and actively participating in numerous conference calls, conferences, and meetings with CDC investigators. Given the significant activities of EIP sites, this FOA provides an opportunity to enhance support for the basic infrastructure of the EIP network.
Link to Full Grant Announcement: Information not provided
Grant Announcement Contact: Centers for Disease Control and Prevention Procurement and Grants Office TIMS Phone 770-488-2700

PGOTIM@cdc.gov [PGOTIM@cdc.gov]
Similar Government Grants: • Patient Protection and Affordable Care Act (ACA), Emerging Infections Programs (EIP), Enhancing Epid...; • Patient Protection and Affordable Care Act Epidemiology and Laboratory Capacity for Infectious Disea...; • Opportunity CDC-RFA-CI10-1012